Classes
- Student Research ActivityC4SVA110 | Third Faculty of Medicine
- Dermatovenerology +3C5VL004 | Third Faculty of Medicine
- Atopic dermatitis +1CCOC6909 | Third Faculty of Medicine
- Dermatology and Diseases of the Mucosa +2CDH003P2 | Third Faculty of Medicine
- ERASMUS - DermatovenerologyCERA5P0076 | Third Faculty of Medicine
- IIC - 10. Cutaneous ChangesCMCP1034 | Third Faculty of Medicine
- IIB - DermatovenerologyCMPRKL23 | Third Faculty of Medicine
- Nursing Care in Dermatovenerology +2CNS012P2 | Third Faculty of Medicine
Publications
- Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy2010 | Third Faculty of Medicine
- Gene expression in actinic keratoses: pharmacological modulation by imiquimod2004 | Third Faculty of Medicine
- Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic2024 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen
- BIOREP - Biologic/Targeted Therapy Registry: 2022 Summary Report2023 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Employing Adalimumab in Treatment of Moderate-to-Severe Hidradenitis Suppurativa: Real-Life Multicenter Data from the Czech Republic2023 | Third Faculty of Medicine, First Faculty of Medicine
- Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 2382023 | Third Faculty of Medicine
- Malignant melanoma: diagnosis and treatment based on current guidelines2023 | Third Faculty of Medicine
- Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies2023 | Third Faculty of Medicine
- Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma2023 | Central Library of Charles University
- European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 20232023 | Third Faculty of Medicine
Loading network view...